Geleen – Langenfeld, May 2024 ARTES Biotechnology and Basic Pharma are almost there! The companies are nearing completion of their joint project with the production of recombinant Human Serum Albumin (rHSA) and the first vials are expected to be available this summer. ARTES, a leading company that specialized in developing and transferring recombinant cell lines […]
https://artes-biotechnology.biz/wp-content/uploads/2023/10/artes-biotechnology-products-e1714654157676.jpg613489Melanie Piontekhttps://artes-biotechnology.biz/wp-content/uploads/2014/11/artes-Logo1-300x137.pngMelanie Piontek2024-05-02 14:50:002024-05-02 14:53:51ARTES and Basic Pharma near completion of their joint rHSA project
Langenfeld, Germany; 10th of January 2024 ARTES Biotechnology GmbH announced today that Volker Jenzelewski reinforces the executive board of ARTES as Managing Director beginning of the year. He will manage the company in close cooperation with Dr. Michael Piontek, Managing Director and founder of ARTES Biotechnology and with Dr. Melanie Piontek, Business Development Director. Volker […]
ARTES Biotechnology and Basic Pharma join in a strategic Collaboration and Co-Marketing Partnership for Pharmaceutical Recombinant Protein Production Geleen – Langenfeld, October 2023 ARTES Biotechnology, a leading company specializing in development and transfer of recombinant cell lines and protein production processes from microbial expression systems and Basic Pharma, a pharmaceutical company focusing on niche […]
https://artes-biotechnology.biz/wp-content/uploads/2014/11/artes-Logo1-300x137.png00Melanie Piontekhttps://artes-biotechnology.biz/wp-content/uploads/2014/11/artes-Logo1-300x137.pngMelanie Piontek2023-10-11 14:53:482023-10-11 14:57:17ARTES and Basic Pharma join in a strategic Collaboration
https://artes-biotechnology.biz/wp-content/uploads/2016/09/Präsentation1a-e1474894505367.jpg7201280Melanie Piontekhttps://artes-biotechnology.biz/wp-content/uploads/2014/11/artes-Logo1-300x137.pngMelanie Piontek2022-07-04 15:49:152023-10-11 13:56:27New Paper Published
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
ARTES and Basic Pharma near completion of their joint rHSA project
Geleen – Langenfeld, May 2024 ARTES Biotechnology and Basic Pharma are almost there! The companies are nearing completion of their joint project with the production of recombinant Human Serum Albumin (rHSA) and the first vials are expected to be available this summer. ARTES, a leading company that specialized in developing and transferring recombinant cell lines […]
ARTES announce expansion of the management board
Langenfeld, Germany; 10th of January 2024 ARTES Biotechnology GmbH announced today that Volker Jenzelewski reinforces the executive board of ARTES as Managing Director beginning of the year. He will manage the company in close cooperation with Dr. Michael Piontek, Managing Director and founder of ARTES Biotechnology and with Dr. Melanie Piontek, Business Development Director. Volker […]
ARTES and Basic Pharma join in a strategic Collaboration
ARTES Biotechnology and Basic Pharma join in a strategic Collaboration and Co-Marketing Partnership for Pharmaceutical Recombinant Protein Production Geleen – Langenfeld, October 2023 ARTES Biotechnology, a leading company specializing in development and transfer of recombinant cell lines and protein production processes from microbial expression systems and Basic Pharma, a pharmaceutical company focusing on niche […]
ARTES’ Proteins for Diagnostics
New Paper Published